Great to see 3's, but this is still extremely unde
Post# of 1525
Add in new revenue streams (340B) and acquisition news, both of which are expected in the near future, and fair value becomes more difficult to quantify without details of such upward catalysts.
Bottom line:
It's worth a lot more than .03 today, and it's worth a lot more than what it's worth today the moment additional news is published.
$RXMD is upside coated with upside.